Northstar Group Inc. Has $1.57 Million Holdings in CVS Health Corp (CVS)
Northstar Group Inc. lowered its stake in shares of CVS Health Corp (NYSE:CVS) by 13.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 21,957 shares of the pharmacy operator’s stock after selling 3,368 shares during the period. Northstar Group Inc.’s holdings in CVS Health were worth $1,568,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in CVS. Beach Investment Management LLC. acquired a new position in CVS Health during the 2nd quarter valued at about $2,224,000. American Century Companies Inc. boosted its stake in CVS Health by 15.2% during the 2nd quarter. American Century Companies Inc. now owns 3,937,374 shares of the pharmacy operator’s stock valued at $316,801,000 after purchasing an additional 519,856 shares during the last quarter. TRUE Private Wealth Advisors boosted its stake in CVS Health by 4.0% during the 2nd quarter. TRUE Private Wealth Advisors now owns 7,212 shares of the pharmacy operator’s stock valued at $580,000 after purchasing an additional 276 shares during the last quarter. GFS Advisors LLC boosted its stake in CVS Health by 9.6% during the 2nd quarter. GFS Advisors LLC now owns 86,142 shares of the pharmacy operator’s stock valued at $6,931,000 after purchasing an additional 7,550 shares during the last quarter. Finally, Alpha Omega Wealth Management LLC boosted its stake in CVS Health by 6.2% during the 2nd quarter. Alpha Omega Wealth Management LLC now owns 35,191 shares of the pharmacy operator’s stock valued at $2,831,000 after purchasing an additional 2,066 shares during the last quarter. Institutional investors and hedge funds own 83.23% of the company’s stock.
Shares of CVS Health Corp (NYSE:CVS) opened at $67.46 on Friday. The company has a quick ratio of 0.52, a current ratio of 1.02 and a debt-to-equity ratio of 0.59. The company has a market cap of $68,125.82, a P/E ratio of 10.43, a P/E/G ratio of 1.11 and a beta of 1.03. CVS Health Corp has a 1-year low of $66.45 and a 1-year high of $84.00.
The business also recently declared a quarterly dividend, which was paid on Friday, February 2nd. Investors of record on Wednesday, January 24th were issued a $0.50 dividend. The ex-dividend date was Tuesday, January 23rd. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.96%. CVS Health’s dividend payout ratio (DPR) is presently 30.91%.
A number of equities analysts have issued reports on the company. Needham & Company LLC upgraded CVS Health from a “buy” rating to a “strong-buy” rating and lifted their price target for the company from $88.00 to $100.00 in a research note on Tuesday, January 30th. Mizuho set a $95.00 target price on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Cowen reissued an “outperform” rating and set a $99.00 target price (up previously from $81.00) on shares of CVS Health in a research report on Thursday, January 18th. Vetr cut shares of CVS Health from a “hold” rating to a “sell” rating and set a $76.66 target price on the stock. in a research report on Tuesday, January 16th. Finally, ValuEngine cut shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Two analysts have rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. CVS Health currently has an average rating of “Buy” and an average price target of $87.03.
In related news, EVP Lisa Bisaccia sold 29,445 shares of CVS Health stock in a transaction that occurred on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total value of $2,208,375.00. Following the sale, the executive vice president now owns 15,556 shares of the company’s stock, valued at approximately $1,166,700. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Helena Foulkes sold 19,965 shares of CVS Health stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $71.04, for a total transaction of $1,418,313.60. Following the completion of the sale, the executive vice president now directly owns 65,072 shares in the company, valued at approximately $4,622,714.88. The disclosure for this sale can be found here. Insiders own 0.61% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/northstar-group-inc-has-1-57-million-holdings-in-cvs-health-corp-cvs/1903979.html.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.